nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Aberrant hippocampal intrinsic morphological connectivity patterns in Neuromyelitis optica spectrum disorder with cognitive impairment: Insights from an individual-based morphological brain network
|
Wang, Xin |
|
|
92 |
C |
p. |
artikel |
2 |
97. Acute Extensive Longitudinal Myelitis: Challenges in Differential Diagnosis between Spinal Cord Ischemia and Inflammatory Disease
|
Imen, Ben Kraiem |
|
|
92 |
C |
p. |
artikel |
3 |
8. Agreement of Large Language Models with Humans in Extracting Data from Unstructured Records of Multiple Sclerosis Patients
|
Alnhwi, Zainab Ali |
|
|
92 |
C |
p. |
artikel |
4 |
AI-assisted assessment of fall risk in multiple sclerosis: A systematic literature review
|
Mehrlatifan, Somayeh |
|
|
92 |
C |
p. |
artikel |
5 |
136. AMALXR: A Home-Based Virtual Self-Rehabilitation Tool for Patients with Multiple Sclerosis
|
Belghith, Mohamed |
|
|
92 |
C |
p. |
artikel |
6 |
14. An Algorithm for Assessment and Correction of Walking in Patients with Multiple Sclerosis
|
Lysogorskaia, Elena |
|
|
92 |
C |
p. |
artikel |
7 |
139. An Update of Systematic Review and Meta-analysis: The Effect of Cigarette Smoking on the Progression of Multiple Sclerosis
|
Ali, Ahmed Essmat |
|
|
92 |
C |
p. |
artikel |
8 |
Appointment non-attendance is associated with disease modifying therapy persistence the following year
|
Gromisch, Elizabeth S. |
|
|
92 |
C |
p. |
artikel |
9 |
A qualitative study on the experiences of autologous haematopoietic stem cell transplant for Multiple Sclerosis
|
Davenport, Laura |
|
|
92 |
C |
p. |
artikel |
10 |
109. A Real-world Data of Serum Neurofilament Light Chain in a Large Cohort of Egyptian Multiple Sclerosis Patients: A Hospital-based Study
|
Khedr, Eman Mohamed |
|
|
92 |
C |
p. |
artikel |
11 |
Artificial neural network-based prediction of multiple sclerosis using blood-based metabolomics data
|
Ata, Nasar |
|
|
92 |
C |
p. |
artikel |
12 |
Assessing and tailoring predictive equations of VO2max for women with multiple sclerosis with mild to moderate disability
|
Morrone, Marco |
|
|
92 |
C |
p. |
artikel |
13 |
93. Assessing the Correlation Between COVID-19 and Immunization Vaccine in Multiple Sclerosis Patients in Riyadh's MNGHA
|
Alanazi, Asma |
|
|
92 |
C |
p. |
artikel |
14 |
Assessing the landscape and charting paths: UK neurology trainees’ opinions on neuroinflammation subspecialty
|
Arun, Tarunya |
|
|
92 |
C |
p. |
artikel |
15 |
122. Assessment of Cognitive Function in Patients with Neuromyelitis Optica Spectrum Disorders (NMOSD) Compared to Patients with Multiple Sclerosis
|
Kasatkin, Dmitry |
|
|
92 |
C |
p. |
artikel |
16 |
131. Assessment of Cognitive Functions, Gait Affaction and Fatigue in Relapsing- remitting Multiple Sclerosis Patients
|
Abdeldayem, Mai Mohamed |
|
|
92 |
C |
p. |
artikel |
17 |
106. Assessment of Depression and Anxiety in Patients with Multiple Sclerosis in Morocco
|
Hind, Bel Amgharia |
|
|
92 |
C |
p. |
artikel |
18 |
40. Assessment of Serum Zonulin as a Marker of Altered Intestinal Permeability in Patients with Multiple Sclerosis
|
Nassief, Ayman M |
|
|
92 |
C |
p. |
artikel |
19 |
142. Assessment of the Quality of Life of Patients with Multiple Sclerosis in Morocco
|
Lotfi, Rachid |
|
|
92 |
C |
p. |
artikel |
20 |
85. Association Between Corpus Callosum Damage and Clinical Disability in Multiple Sclerosis
|
Farhat, Nouha |
|
|
92 |
C |
p. |
artikel |
21 |
60. Atypical Presentation of Anti-MOG antibody-associated Disease: Aseptic Meningitis and Arachnoiditis
|
Imen, Ben Kraiem |
|
|
92 |
C |
p. |
artikel |
22 |
117. Atypical Presentation of NMOSD Revealed by Trigeminal Neuralgia
|
Bouattor, Nadia |
|
|
92 |
C |
p. |
artikel |
23 |
98. Balò concentric sclerosis or glioma? A case of a challenging diagnosis
|
Farhat, Nouha |
|
|
92 |
C |
p. |
artikel |
24 |
178. B-cell Levels and Placental Transfer in Infants Potentially Exposed to Ocrelizumab During Pregnancy: Primary Analysis of the Prospective Multicentre, Open-label Phase IV MINORE study
|
Hellwig, K. |
|
|
92 |
C |
p. |
artikel |
25 |
175. B-cell Levels in Infants of Lactating Women with Multiple Sclerosis Receiving Ocrelizumab: SOPRANINO Primary Results
|
Hellwig, K |
|
|
92 |
C |
p. |
artikel |
26 |
Blood neutrophils, oligoclonal bands and bridging corticosteroids as predictive factors for MOGAD course: Insights from a multicentric Portuguese cohort
|
Neves, Ana Lídia |
|
|
92 |
C |
p. |
artikel |
27 |
44. Breaking Free from the Six-Month Cycle
|
Al-Draye, Hamad |
|
|
92 |
C |
p. |
artikel |
28 |
171. Cardiac Abnormalities Associated with Fingolimod Initiation in a Real-Life Cohort
|
Aljarallah, Salman |
|
|
92 |
C |
p. |
artikel |
29 |
29. Central Vein Sign Assessment in Multiple Sclerosis: A Multi-Parametric Approach
|
Hannoun, Salem |
|
|
92 |
C |
p. |
artikel |
30 |
35. Cerebrospinal Fluid and Serum Neurofilament Light Chain Levels at Baseline Predict Disease Activity and Severity in Neuromyelitis Optica Spectrum Disorder Patients
|
Mrabet, Saloua |
|
|
92 |
C |
p. |
artikel |
31 |
159. Cladribine Tablets Use in People with Multiple Sclerosis Up to 4 Years and Beyond Following Treatment Initiation: Results from Multi-country Patient Support Programmes
|
Oh, Jiwon |
|
|
92 |
C |
p. |
artikel |
32 |
Clinical characteristics of pediatric and adult myelin oligodendrocyte antibody-associated disease (MOGAD): A single-center study in the Northeast
|
Brown, Allison M |
|
|
92 |
C |
p. |
artikel |
33 |
46. Clinical overlap of multiple sclerosis and autoimmune hepatitis: A coincidental association? A case report and review of the literature
|
Paybast, Sepideh |
|
|
92 |
C |
p. |
artikel |
34 |
6. Clinical Overlap of Multiple Sclerosis and Primary Biliary Cirrhosis: A Coincidental Association - A Case Report and Review of the Literature
|
Paybast, Sepideh |
|
|
92 |
C |
p. |
artikel |
35 |
9. Clinical Profile of Seizures in Multiple Sclerosis Patients in a Tertiary Care Center
|
Alrushid, Eythar |
|
|
92 |
C |
p. |
artikel |
36 |
105. Clinical Relevance of Circular RNA circ_0005402 Expression in Multiple Sclerosis in a Cohort of Egyptian Patients
|
Nasr, Nada Mohamed Nasr |
|
|
92 |
C |
p. |
artikel |
37 |
Coexistence of epilepsy or seizure and multiple sclerosis; a single center experience
|
Saridas, Furkan |
|
|
92 |
C |
p. |
artikel |
38 |
56. Coffee and Caffeine as a Cognitive Enhancer in Multiple Sclerosis: A Systematic Review
|
Salekzamani, Shabnam |
|
|
92 |
C |
p. |
artikel |
39 |
57. Cognitive Decline and Motor Handicap in Multiple Sclerosis Patients
|
Farhat, Nouha |
|
|
92 |
C |
p. |
artikel |
40 |
169. Combining Metformin and Clemastine for Enhanced Remyelination in Multiple Sclerosis
|
Alskaf, Asma Samir |
|
|
92 |
C |
p. |
artikel |
41 |
130. Community Mobility in Patients with Multiple Sclerosis in Saudi Arabia – A Qualitative Study Analysis
|
Basharahil, Saja Omar |
|
|
92 |
C |
p. |
artikel |
42 |
Comorbidities and their association with outcomes in the multiple sclerosis population: A rapid review
|
Frank, Hanna A. |
|
|
92 |
C |
p. |
artikel |
43 |
47. Comparison of Fingolimod vs. Dimethyl Fumarate as Naïve Treatment in Patients with Relapse-remitting Multiple Sclerosis: A Five-year Follow-up Study
|
Paybast, Sepideh |
|
|
92 |
C |
p. |
artikel |
44 |
61. Co-occurrence of Anti-MuSK Myasthenia Gravis and Multiple Sclerosis: A Case Report and Literature Review
|
Bakharji, Ahmed |
|
|
92 |
C |
p. |
artikel |
45 |
112. Correlation of Magnetic Resonance Imaging with cognitive impairment in Multiple Sclerosis
|
Farhat, Nouha |
|
|
92 |
C |
p. |
artikel |
46 |
148. Correlations Between Cognitive Impairment and Multiple Sclerosis Treatments
|
Farhat, Nouha |
|
|
92 |
C |
p. |
artikel |
47 |
Corrigendum to “Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment” [Multiple Sclerosis and Related Disorders, Volume 79, November 2023, https://doi.org/10.1016/j.msard.2023.104949]
|
Sen, Sedat |
|
|
92 |
C |
p. |
artikel |
48 |
135. Cost Effectiveness of Rapid Infusion Time of Ocrelizumab and Can Safely Be Delivered in Saudi Tertiary Hospital
|
Alhartani, Mohammed Muneer |
|
|
92 |
C |
p. |
artikel |
49 |
De-escalation from anti-CD20 to cladribine tablets in multiple sclerosis: A pilot study
|
Sacco, Rosaria |
|
|
92 |
C |
p. |
artikel |
50 |
18. Demographics and Clinical Assessment of Familial Multiple Sclerosis Patients in Ain Shams University Hospitals
|
Abdulnaser, Azza |
|
|
92 |
C |
p. |
artikel |
51 |
Development and psychometric evaluation of the treatment management adherence scale for children with multiple sclerosis
|
Yüksel, Didem |
|
|
92 |
C |
p. |
artikel |
52 |
Development of a new patient-reported outcome measure for patients with multiple sclerosis: the Multiple Sclerosis Autonomy Scale (MSAS)
|
Donzé, Cécile |
|
|
92 |
C |
p. |
artikel |
53 |
Development, validity and reliability of the “Multiple sclerosis stigma scale”
|
Sariahmetoglu, Hande |
|
|
92 |
C |
p. |
artikel |
54 |
62. Diagnostic and Therapeutic Challenges in Seronegative Forms of Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis: A Case Report
|
Imen, Ben Kraiem |
|
|
92 |
C |
p. |
artikel |
55 |
16. Diagnostic Utility of the Central Vein Sign in Multiple Sclerosis with Implementation of the 6 Lesion Rule
|
Alsalamah, Seham |
|
|
92 |
C |
p. |
artikel |
56 |
107. Differential Gene Expression in Bahraini Patients with Multiple Sclerosis
|
Alnashmi, Moudhi Essa |
|
|
92 |
C |
p. |
artikel |
57 |
141. Digital Impact on the Management of Multiple Sclerosis
|
Costa, Jad |
|
|
92 |
C |
p. |
artikel |
58 |
25. Disconnection and Atrophy in Brain Regions of MS Converters: Insights into Disease Progression
|
Hannoun, Salem |
|
|
92 |
C |
p. |
artikel |
59 |
155. Disease-Modifying Drugs Effect on Plasmacytoid Dendritic Cells in Multiple Sclerosis Patients
|
Rageh, Tarek |
|
|
92 |
C |
p. |
artikel |
60 |
38. Diverse Clinical Patterns and Outcomes in MOG Related Disorders in Adults: Insights from a Multi-center Study in Pakistan
|
Imtiaz, Hina |
|
|
92 |
C |
p. |
artikel |
61 |
32. Does Quantitative MRI Parameters Help To Solve The Clinic-Radiological Paradox in Multiple Sclerosis?
|
El-Tallawy, Hamdy N |
|
|
92 |
C |
p. |
artikel |
62 |
67. Domain-Specific and Global Cognitive Impairment in Multiple Sclerosis Patients Based on Cambridge Neuropsychological Test Automated Battery
|
Sahebari, Sepideh Seyedi |
|
|
92 |
C |
p. |
artikel |
63 |
69. Do People with Multiple Sclerosis in Saudi Arabia Want to Know their Prognosis? A Cross-sectional Nationwide Study
|
Malik, Yaser M. Al |
|
|
92 |
C |
p. |
artikel |
64 |
127. Early Progression to Secondary Progressive Multiple Sclerosis in South Tunisia
|
Bouaziz, Fatma |
|
|
92 |
C |
p. |
artikel |
65 |
Early rituximab versus escalating therapy in neuromyelitis optica: A cost and quality of life analysis
|
Silva, Guilherme Diogo |
|
|
92 |
C |
p. |
artikel |
66 |
50. Effectiveness of 6-week Dosing of Natalizumab Versus Continued 4-Week Treatment for Multiple Sclerosis: An Observational Registry-Based Study
|
Alroughani, Raed |
|
|
92 |
C |
p. |
artikel |
67 |
Effects of multiple treatments with stem cell therapy in patients with multiple sclerosis
|
Fan, Liding |
|
|
92 |
C |
p. |
artikel |
68 |
11. Effects of Trunk Rehabilitation on Balance, Gait, Fall and Community Mobility in Patients with Multiple Sclerosis: A Randomised Clinical Trial
|
Mukhtar, Shatha Mohammed |
|
|
92 |
C |
p. |
artikel |
69 |
167. Efficacy and Safety of Natalizumab: Follow up and Real-life Results of an Algerian Hospital Series
|
Kediha, Mohamed Islam |
|
|
92 |
C |
p. |
artikel |
70 |
153. Efficacy and Safety of Tolebrutinib Versus Placebo in Non-Relapsing Secondary Progressive Multiple Sclerosis: Results From the Phase 3 HERCULES Trial
|
Fox, Robert J. |
|
|
92 |
C |
p. |
artikel |
71 |
154. Efficacy and Safety of Tolebrutinib Versus Teriflunomide in Relapsing Multiple Sclerosis: Results From the Phase 3 GEMINI 1 and 2 Trials
|
Oh, Jiwon |
|
|
92 |
C |
p. |
artikel |
72 |
152. Efficacy of Frexalimab on Physical and Psychological Impacts and Fatigue in Relapsing Multiple Sclerosis: Findings from MSIS-29v2 and PROMIS-Fatigue-MS-8a Assessments in a Phase 2 Trial
|
Vermersch, Patrick |
|
|
92 |
C |
p. |
artikel |
73 |
144. Efficacy of Ocrelizumab in Multiple Sclerosis Patients in Saudi Arabia: A Registry-Based Study
|
Althobaiti, Ahmed |
|
|
92 |
C |
p. |
artikel |
74 |
173. Efficacy of Pulsed Electromagnetic Field Therapy on Fatigue for Patients with Multiple Sclerosis: A Systematic Review and Meta-Analysis
|
Mansour, Mohamed Ezzat Mahmoud |
|
|
92 |
C |
p. |
artikel |
75 |
24. Enhancing Cognitive Function and Neuroplasticity Assessed by Diffusion Tensor imagin in Multiple Sclerosis: The Efficacy of Combined Transcranial Direct Current Stimulation and Application-Assisted Cognitive Rehabilitation
|
Roozbeh, Mehrdad |
|
|
92 |
C |
p. |
artikel |
76 |
Epstein-Barr nuclear antigen 1 antibody-based indices are increased in patients with multiple sclerosis
|
Ali, Rimsha |
|
|
92 |
C |
p. |
artikel |
77 |
Establishing consensus on lifestyle recommendations and behaviour change strategies to promote brain health-focussed care for multiple sclerosis: A modified e-Delphi study
|
Wills, Olivia |
|
|
92 |
C |
p. |
artikel |
78 |
54. Ethical Dilemmas Revolving Around Use of Medical Cannabis for MS in Pakistan
|
Ashfaq, Ayesha |
|
|
92 |
C |
p. |
artikel |
79 |
Etiology and characteristics of pseudotumoral lesions and tumefactive demyelination in multiple sclerosis
|
Tamas, Olivera |
|
|
92 |
C |
p. |
artikel |
80 |
180. Evaluation of the Cost-effectiveness of Ofatumumab for Relapsing Multiple Sclerosis in the United Arab Emirates
|
Inshasi, Jihad |
|
|
92 |
C |
p. |
artikel |
81 |
34. Evaluation of the Predictive Value of the Bands CSF Oligoclonals on the Prognosis in Terms of Disability and Risk of rRelapse in Patients Adults with MOGAD
|
Baitha, Khadija |
|
|
92 |
C |
p. |
artikel |
82 |
43. Experience with Autologous Stem Cell Transplant in Multiple Sclerosis in the UAE
|
Mir, Ruqqia |
|
|
92 |
C |
p. |
artikel |
83 |
13. Explaining the Clinical and MRI Dissociation in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
|
Ali, Eman Nassim |
|
|
92 |
C |
p. |
artikel |
84 |
73. Exploring Risk Factors for the Severity of Bowel Dysfunction, Urinary Dysfunction, and Fatigue in Multiple Sclerosis
|
Ketata, Imen |
|
|
92 |
C |
p. |
artikel |
85 |
Exploring the impact of wearing-off phenomenon in ocrelizumab-treated multiple sclerosis patients: Insights from a comprehensive study
|
Seferoğlu, Meral |
|
|
92 |
C |
p. |
artikel |
86 |
138. Factors Affecting the Quality of Sleep and Physical Activity Participation of Multiple Sclerosis (MS) Patients: A Path Analysis
|
Khalil, Hanan |
|
|
92 |
C |
p. |
artikel |
87 |
126. Familial Pediatric Onset Multiple Sclerosis: A Retrospective Single-Center Observational Study
|
Majoul, Mohamed Slim |
|
|
92 |
C |
p. |
artikel |
88 |
177. Fenebrutinib Maintains Low Disease Activity in Relapsing Multiple Sclerosis: Results from the FENopta Trial Open-label Extension
|
Bar-Or, Amit |
|
|
92 |
C |
p. |
artikel |
89 |
Frailty in multiple sclerosis: A scoping review
|
Al Worikat, Nida’ |
|
|
92 |
C |
p. |
artikel |
90 |
66. Frequency and Predictors of Cognitive Impairment Among Drug–Naïve Multiple Sclerosis Patients: Hospital-based study
|
Khedr, Eman M |
|
|
92 |
C |
p. |
artikel |
91 |
Frequency of anti-MOG antibodies in serum and CSF of patients with possible autoimmune encephalitis: Results from a Brazilian multicentric study
|
de Freitas Dias, Bruna |
|
|
92 |
C |
p. |
artikel |
92 |
150. Frexalimab in Relapsing Multiple Sclerosis and Non-Relapsing Secondary Progressive Multiple Sclerosis: Design of Phase 3 Frexalt and Freviva Trials
|
Krieger, Stephen |
|
|
92 |
C |
p. |
artikel |
93 |
110. Frexalimab Reduces Plasma Neurofilament Light Chain in Relapsing Multiple Sclerosis: Week 48 Data from a Phase 2 Trial
|
Kuhle, J. |
|
|
92 |
C |
p. |
artikel |
94 |
81. Gender Difference In Egyptian Patients With Multiple Sclerosis
|
Hammad, Mohamed Ahmed |
|
|
92 |
C |
p. |
artikel |
95 |
88. Gender Issues in Multiple Sclerosis
|
Kacem, Amal Hadj |
|
|
92 |
C |
p. |
artikel |
96 |
137. Gender-related Quality of Life in People with Multiple Sclerosis
|
Souissi, Amira |
|
|
92 |
C |
p. |
artikel |
97 |
91. Headache and Multiple Sclerosis: Is It Disease Related or Treatment Related?
|
Younis, Hossam Hamdy Abdelhady |
|
|
92 |
C |
p. |
artikel |
98 |
History of head trauma and the risk of multiple sclerosis: A systematic review and meta-analysis
|
Abouelmagd, Moaz Elsayed |
|
|
92 |
C |
p. |
artikel |
99 |
9-HODE associates with thalamic atrophy and predicts white matter damage in multiple sclerosis
|
Fung, Wing Hee |
|
|
92 |
C |
p. |
artikel |
100 |
82. Idiopathic Intracranial Hypertension as A Presenting Symptom of Multiple Sclerosis: A Case Report
|
Meshref, Mostafa |
|
|
92 |
C |
p. |
artikel |
101 |
134. Impact of Bowel Dysfunction, Urinary Dysfunction, and Fatigue on Quality of Life in Multiple Sclerosis
|
Ketata, Imen |
|
|
92 |
C |
p. |
artikel |
102 |
Impact of insurance status on MRI phenotypes in MS
|
Martin, Melissa Lynne |
|
|
92 |
C |
p. |
artikel |
103 |
1. Impact of Menopause on Quality of Life in Multiple Sclerosis Patients
|
Oreja-Guevara, Celia |
|
|
92 |
C |
p. |
artikel |
104 |
133. Impact of Multiple Sclerosis on Professional Activity
|
Farah, Kchaou |
|
|
92 |
C |
p. |
artikel |
105 |
132. Impact of Multiple Sclerosis on Social Participation: A Study of 41 Tunisian Patients
|
Farah, Kchaou |
|
|
92 |
C |
p. |
artikel |
106 |
74. Impact of Vascular Disease Risk Factors on Multiple Sclerosis
|
Dridi, Fawez |
|
|
92 |
C |
p. |
artikel |
107 |
55. Impact of Vitamin D Deficiency on Multiple Sclerosis Patients in Central Saudi Arabia
|
Alsheikh, Sara |
|
|
92 |
C |
p. |
artikel |
108 |
Implementing a multidisciplinary approach for older adults with multiple sclerosis: Geriatric neurology in practice
|
Bahri, Mara |
|
|
92 |
C |
p. |
artikel |
109 |
Improvement in depressive symptoms is associated with sustained improvement in fatigue impact in adults with multiple sclerosis
|
Knowles, Lindsey M. |
|
|
92 |
C |
p. |
artikel |
110 |
Improvement of fatigue, depression, and processing speed two weeks post Natalizumab infusion in Multiple Sclerosis: No difference between standard and extended interval dosing schedules
|
Leodori, Giorgio |
|
|
92 |
C |
p. |
artikel |
111 |
Improving manual dexterity using ergonomic wearable glove in patients with multiple sclerosis: A quasi-randomized clinical trial
|
Ciatto, Laura |
|
|
92 |
C |
p. |
artikel |
112 |
Inflammatory vaginitis in women with multiple sclerosis: a retrospective analysis of B-cell depleting therapy compared to other disease modifying therapies
|
Conway, Sarah |
|
|
92 |
C |
p. |
artikel |
113 |
Interleukin-6 inhibitors for neuromyelitis optica spectrum disorder (NMOSD): A systematic review and meta-analysis
|
Noll, Giovani |
|
|
92 |
C |
p. |
artikel |
114 |
58. Intermediate Uveitis Revealing Multiple Sclerosis
|
Hadjkacem, Donia |
|
|
92 |
C |
p. |
artikel |
115 |
125. Investigating Psychoses in Pediatric-Onset Multiple Sclerosis: A Systematic Review of Case Reports
|
Ketata, Imen |
|
|
92 |
C |
p. |
artikel |
116 |
86. Investigating the Correlation between Pregnancy History, Oral Contraceptive Pill Use, and Cognitive Function in Patients with Multiple Sclerosis
|
Rezaeimanesh, Nasim |
|
|
92 |
C |
p. |
artikel |
117 |
48. Investigating Treatment Alternatives for Fingolimod in Patients with Multiple sclerosis Developed Refractory Fingolimod-related Genital Human Papilloma Virus Infection
|
Paybast, Sepideh |
|
|
92 |
C |
p. |
artikel |
118 |
Is sedentary behavior associated with body composition in multiple sclerosis?
|
Jeng, Brenda |
|
|
92 |
C |
p. |
artikel |
119 |
Is there a relationship between CSF Interleukin 34 Level and clinicoradiological activity and IgG index in patients with MS?
|
Gökçe, Şeyda Figül |
|
|
92 |
C |
p. |
artikel |
120 |
116. Late-onset Neuromyelitis Optica Spectrum Disorders: Clinical, Radiological Features and Prognostic Factors
|
Othman, Oumayma Ben |
|
|
92 |
C |
p. |
artikel |
121 |
5. Late-onset Neutropenia in a Cohort of Central Nervous System Autoimmunity Patients Treated with Anti-CD20
|
Althobaiti, Ahmed H. |
|
|
92 |
C |
p. |
artikel |
122 |
149. Long-term Disease Activity and Disability Progression of Relapsing-Remitting Multiple Sclerosis in patients with Natalizumab: A Single-Centre Retrospective Observational Study
|
Majoul, Mohamed Slim |
|
|
92 |
C |
p. |
artikel |
123 |
162. Long-term Effectiveness of Cladribine Tablets over 4 years in Relapsing Multiple Sclerosis: Results from the MAGNIFY-MS Extension Study
|
De Stefano, Nicola |
|
|
92 |
C |
p. |
artikel |
124 |
161. Long-term Effects of Cladribine Tablets Treatment on Cognition, Relapses, MRI, and Safety Outcomes in Patients with Relapsing Multiple Sclerosis: 4‑year Results from the CLARIFY-MS Extension study
|
Selmaj, Krzysztof |
|
|
92 |
C |
p. |
artikel |
125 |
Long-term follow-up MR imaging in children with transverse myelitis
|
El Naggar, Ines |
|
|
92 |
C |
p. |
artikel |
126 |
52. Long-term Real-world Safety and Efficacy of Cladribine in Patients with Relapsing-Remitting Multiple Sclerosis: The UAE Experience
|
Yamout, Bassem |
|
|
92 |
C |
p. |
artikel |
127 |
45. Lost in Transition: Understanding Fingolimod Withdrawal and its Impact on Multiple Sclerosis Patients
|
Al-Draye, Hamad |
|
|
92 |
C |
p. |
artikel |
128 |
160. Low Rate of Progression Independent of Relapse Activity (PIRA) in Patients with Relapsing Multiple Sclerosis Treated with Cladribine Tablets
|
De Stefano, Nicola |
|
|
92 |
C |
p. |
artikel |
129 |
166. Management of Multiple Sclerosis from Patients', Physicians', and Patient Group's Perspectives in Saudi Arabia
|
Aljarallah, Salman |
|
|
92 |
C |
p. |
artikel |
130 |
115. Marbled Thalamus Appearance: A Radiological Feature Suggestive of Neuromyelitis Optica Spectrum Disorder (NMOSD)
|
Nouri, Dorsaf |
|
|
92 |
C |
p. |
artikel |
131 |
94. MRI Findings in Neuro-Behçet's Disease: A 7-Year Retrospective Study
|
Asma, Ben Khalifa |
|
|
92 |
C |
p. |
artikel |
132 |
Multiple Sclerosis and biological definitions in neurodegenerative diseases
|
Camara-Lemarroy, Carlos R. |
|
|
92 |
C |
p. |
artikel |
133 |
68. Multiple Sclerosis and Epilepsy: Much More Than a Coincidence
|
Daoud, Sawsan |
|
|
92 |
C |
p. |
artikel |
134 |
Multiple sclerosis-associated uveitis in Persian population, a multicenter study
|
Anvari, Pasha |
|
|
92 |
C |
p. |
artikel |
135 |
Multiple sclerosis disease-modifying therapy use in the department of veteran affairs and Medicare: A comparative analysis
|
Hartung, Daniel M. |
|
|
92 |
C |
p. |
artikel |
136 |
15. Multiple Sclerosis Mimicrs on Imaging: A Pictorial Review
|
Al-Draye, Hamad |
|
|
92 |
C |
p. |
artikel |
137 |
Multiple sclerosis: Pregnancy, fertility, and assisted reproductive technology–a review
|
Oreja-Guevara, Celia |
|
|
92 |
C |
p. |
artikel |
138 |
21. Multiple Sclerosis Prevalence among Tehran Residence: Updates from MS registry of Iran
|
Eskandarieh, Sharareh |
|
|
92 |
C |
p. |
artikel |
139 |
143. Navigating the Maze of Multiple Sclerosis Disease Modifying Therapies: Insights from Iran's National MS Registry
|
Ezabadi, Sajjad Ghane |
|
|
92 |
C |
p. |
artikel |
140 |
Neurofilament light in serum: Reference values and effect of risk factors for multiple sclerosis
|
Søndergaard, Helle Bach |
|
|
92 |
C |
p. |
artikel |
141 |
41. Neuropathic Pain in Multiple Sclerosis
|
Farah, Kchaou |
|
|
92 |
C |
p. |
artikel |
142 |
42. Neuropathic Pain in Multiple Sclerosis: Serum Biomarkers and Correlation with MRI Lesion Localization
|
Sarhan, Noha T |
|
|
92 |
C |
p. |
artikel |
143 |
New insights into the use of high dose corticosteroids and plasmapheresis in persons with MOGAD and NMOSD
|
Kosior, N |
|
|
92 |
C |
p. |
artikel |
144 |
Non-invasive brain stimulation enhances the effect of physiotherapy for balance and mobility impairment in people with Multiple Sclerosis.
|
Ghosh, Soumya |
|
|
92 |
C |
p. |
artikel |
145 |
Observational study of gadolinium-enhancing lesions in MRI in patients with multiple sclerosis from the Spanish Mediterranean coast: Seasonal variability and relationship with climatic factors
|
Romero Del Rincón, Celia |
|
|
92 |
C |
p. |
artikel |
146 |
168. Ocrelizumab in Real Clinical Practice of one Municipal Clinical Hospital in Moscow: Experience of Prescription, Safety and Efficacy Problems
|
Kukushkina, Anna |
|
|
92 |
C |
p. |
artikel |
147 |
179. Ocrelizumab Subcutaneous Injection in Patients with Multiple Sclerosis: Further Characterisation of the Benefit–risk Profile from the OCARINA Clinical Development Programme
|
Newsome, S.D. |
|
|
92 |
C |
p. |
artikel |
148 |
3. Outcome of Multiple Sclerosis with and without Optic Neuritis
|
Alshyaokh, Fatima |
|
|
92 |
C |
p. |
artikel |
149 |
119. Paraneoplastic Devic's Disease
|
Farhat, Nouha |
|
|
92 |
C |
p. |
artikel |
150 |
92. Paroxysmal Dystonia Presenting as the First Sign of Multiple Sclerosis: A case report
|
Rekia, Adjmi Roumaissa |
|
|
92 |
C |
p. |
artikel |
151 |
59. Patient Perspectives and Nursing Satisfaction in the Evaluation of High Efficacy Treatment in Multiple Sclerosis: A Cross-sectional Study
|
Pastore, Francesco |
|
|
92 |
C |
p. |
artikel |
152 |
Patterns of cognitive decline across different multiple sclerosis clinical courses
|
Negreiros, André Augusto Lemos Vidal de |
|
|
92 |
C |
p. |
artikel |
153 |
95. Patterns of Corpus Callosum Lesions in Demyelinating Diseases of the Central Nervous System
|
Hafsa, Meriem Ben |
|
|
92 |
C |
p. |
artikel |
154 |
99. Pediatric Multiple Sclerosis Altered Diagnosis in a Tertiary Referral Center: A Retrospective Study
|
Jahani, Shima |
|
|
92 |
C |
p. |
artikel |
155 |
Perturbed microbial ecology in neuromyelitis optica spectrum disorder: Evidence from the gut microbiome and fecal metabolome
|
Xie, QinFang |
|
|
92 |
C |
p. |
artikel |
156 |
170. Physical Activity and Fatigue in Multiple Sclerosis Patients
|
Sakka, Salma |
|
|
92 |
C |
p. |
artikel |
157 |
129. Physical Activity and Inflammatory Markers in Multiple Sclerosis Patients: A Study of a Tunisian cohort
|
Sakka, Salma |
|
|
92 |
C |
p. |
artikel |
158 |
Physical activity improves cardiovascular fitness and reduces cardiovascular risk factors in adults with multiple sclerosis: A systematic review and meta-analysis
|
Lin, Chun-Chen |
|
|
92 |
C |
p. |
artikel |
159 |
140. Physicians’ Perspectives on Barriers to Multiple Sclerosis Care in United Arab Emirates: A Survey Study
|
Mir, Ruqqia |
|
|
92 |
C |
p. |
artikel |
160 |
Plasma levels of polyunsaturated fatty acids and multiple sclerosis susceptibility in a US case-control study
|
Dunlop, Eleanor |
|
|
92 |
C |
p. |
artikel |
161 |
146. Post-Approval Safety of Cladribine Tablets in the Treatment of Patients With Multiple Sclerosis: 2024 Update
|
Leist, Thomas |
|
|
92 |
C |
p. |
artikel |
162 |
Preceding hepatitis B virus infection is highly prevalent in patients with neuromyelitis optica spectrum disorder in Taiwan
|
Ou Yang, Wen-Yu |
|
|
92 |
C |
p. |
artikel |
163 |
Predicting faller status in persons with multiple sclerosis using the Multiple Sclerosis Walking Scale-12
|
Abate, Caterina |
|
|
92 |
C |
p. |
artikel |
164 |
Preferences and attitudes regarding early intervention in multiple sclerosis: A systematic literature review
|
Martin, Sylvia |
|
|
92 |
C |
p. |
artikel |
165 |
176. Pregnancy and Infant Outcomes in Women with Multiple Sclerosis Receiving Ocrelizumab: Analysis of Approximately 4,000 Pregnancies To Date
|
Dobson, R |
|
|
92 |
C |
p. |
artikel |
166 |
49. Pregnancy Outcomes Following Maternal and Paternal Exposure to Teriflunomide
|
Rashed, Mohamed Abdalla |
|
|
92 |
C |
p. |
artikel |
167 |
7. Pregnancy Outcomes in Patients with Multiple Sclerosis with or without Exposure to Disease-Modifying Treatment: A Retrospective Cohort Study on Iranian Population
|
Paybast, Sepideh |
|
|
92 |
C |
p. |
artikel |
168 |
65. Prevalence and Factors Contributing for Developing Cognitive Impairment Among 200 Multiple Sclerosis Patients: A Hospital Based Study
|
Khedr, Eman M |
|
|
92 |
C |
p. |
artikel |
169 |
172. Prevalence and Impact of Complementary and Alternative Medicine Use Among Multiple Sclerosis Patients in Saudi Arabia
|
Aljarallah, Salman |
|
|
92 |
C |
p. |
artikel |
170 |
128. Prevalence and Impact of Digestive Disorders in Multiple Sclerosis in a Hospital Cohort
|
Imen, Ben Kraiem |
|
|
92 |
C |
p. |
artikel |
171 |
72. Prevalence, Characteristics and Risk Factors of Seizures Among Patients with Multiple Sclerosis
|
Aljarallah, Salman |
|
|
92 |
C |
p. |
artikel |
172 |
63. Prevalence of Anxiety and its Associated Factors in Multiple Sclerosis: Insights from an Algerian Cohort
|
Khermache, Ali |
|
|
92 |
C |
p. |
artikel |
173 |
19. Prevalence of multiple sclerosis in Al Quseir city, Red Sea Governorate, Egypt
|
El-Tallawy, Hamdy N. |
|
|
92 |
C |
p. |
artikel |
174 |
76. Prevalence of Sleep Disorders and Their Impact on Quality of Life in a Large Cohort of Patients with MS: A Hospital based study
|
Khedr, Eman M |
|
|
92 |
C |
p. |
artikel |
175 |
75. Prevelance of Primary Headache in Iraqi Patients with Relapsing Remitting Multiple Sclerosis
|
Algburi, Saif Mohammed |
|
|
92 |
C |
p. |
artikel |
176 |
22. Prodromal or Early Multiple Sclerosis: An Algerian Case-Control Study of Emerging Evidence and Utility
|
Kediha, Mohamed Islam |
|
|
92 |
C |
p. |
artikel |
177 |
114. Prognosis Predictors in Neuromyelitis Optica Spectrum Disorder: A Tunisian Cohort Study
|
Othman, Oumayma Ben |
|
|
92 |
C |
p. |
artikel |
178 |
Progressive multifocal leukoencephalopathy associated with sphingosine-1-phosphate receptor modulators: A large case series
|
Croteau, David |
|
|
92 |
C |
p. |
artikel |
179 |
174. Prolonged B-Cell Depletion Post-Rituximab in a Patient with Neuromyelitis Optica Spectrum Disorder (NMO-SD): A Case Report with Literature Review
|
Samad, Omar Abdel |
|
|
92 |
C |
p. |
artikel |
180 |
164. Prospective Multi Centered Study on the Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis Patients
|
Al-Mahdawi, Akram M. |
|
|
92 |
C |
p. |
artikel |
181 |
101. Pseudotumor Demyelinating Lesions in Inflammatory Diseases of the Central Nervous System: An Algerian Series
|
Kediha, Mohamed Islam |
|
|
92 |
C |
p. |
artikel |
182 |
64. Psychological and Sexual Health in MS Patients: Findings from an Algerian Cohort
|
Khermache, Ali |
|
|
92 |
C |
p. |
artikel |
183 |
Psychometric properties of patient-reported outcome measures, measuring fatigue in patients with multiple sclerosis, a systematic review
|
Ruzzi, Miguel Angel Jorquera |
|
|
92 |
C |
p. |
artikel |
184 |
147. Quality of Life and Treatment Satisfaction in Relapsing-Remitting Multiple Sclerosis: A Comparative Analysis of Dimethyl Fumarate (DMF) in Switchers and Treatment-Naïve Patients
|
Abolfazli, Roya |
|
|
92 |
C |
p. |
artikel |
185 |
26. Quantitative Evaluation of Lesion Load in Multiple Sclerosis using Multimodal MR
|
Wen, Puti |
|
|
92 |
C |
p. |
artikel |
186 |
31. Quantitative susceptibility mapping (QSM)-based regional iron concentration: Does it correlate with brain volume loss? An analysis of 250 regions of interest (ROIs)
|
Hamdy, Eman |
|
|
92 |
C |
p. |
artikel |
187 |
123. Rare Association Between Neuromyelitis Optica Spectrum Disorder, Anti-synthetase Syndrome and Systemic Lupus Erythematosus in an Adult Female
|
Kediha, Mohamed Islam |
|
|
92 |
C |
p. |
artikel |
188 |
163. Real-Life Impact of Fingolimod on Multiple Sclerosis Treatment
|
Aljahdali, Naila |
|
|
92 |
C |
p. |
artikel |
189 |
70. Real-World Experience of Cladribine Tablets in the Treatment of Multiple Sclerosis: An Omani Cohort from Khoula Hospital
|
Redha, Iman |
|
|
92 |
C |
p. |
artikel |
190 |
89. Real-world Safety and Efficacy of Teriflunomide (Tebazio®) in Iranian Females with Relapsing-Remitting Multiple Sclerosis
|
Sabeti, Fatemeh |
|
|
92 |
C |
p. |
artikel |
191 |
28. Relationship between Neurofilament Light Chain levels and Disability Progression in Patients with Multiple Sclerosis
|
Mrabet, Saloua |
|
|
92 |
C |
p. |
artikel |
192 |
157. Remibrutinib Exposure in Cerebrospinal Fluid: Insights from a Study in Healthy Subjects
|
Lefèvre, Gilbert |
|
|
92 |
C |
p. |
artikel |
193 |
103. Risk Factors Affecting the Age at Onset in Adult Patients with Multiple Sclerosis
|
Lapevandani, Mahsa Mohammadi |
|
|
92 |
C |
p. |
artikel |
194 |
53. Risk of Malignancy and the Use of Disease-Modifying Therapy in Multiple Sclerosis: Exploring the Role of DMT in a Multi-Center Study
|
Bayounis, Mohammed |
|
|
92 |
C |
p. |
artikel |
195 |
151. Safety and Efficacy of Frexalimab in the Treatment of Relapsing Multiple Sclerosis: 18-month Results from the Phase 2 Open-Label Extension
|
Giovannoni, Gavin |
|
|
92 |
C |
p. |
artikel |
196 |
156. Safety of Remibrutinib across Immune-mediated Diseases Supports Development in Multiple Sclerosis
|
Kieseier, Bernd C. |
|
|
92 |
C |
p. |
artikel |
197 |
17. Season of Birth and Multiple Sclerosis in the Middle East and North Africa
|
Ali, Mohammad Aboulwafa |
|
|
92 |
C |
p. |
artikel |
198 |
Segmental abnormalities of white matter microstructure in multiple sclerosis and neuromyelitis optica spectrum disorder identified by automated fiber quantification
|
Xie, Yan |
|
|
92 |
C |
p. |
artikel |
199 |
118. Seroconversion in Neuromyelitis Optica Spectrum Disorder
|
Hadjkacem, Donia |
|
|
92 |
C |
p. |
artikel |
200 |
108. Serum Biomarkers and Their Association with Clinical, Cognitive, and Quality of Life Parameters in Disease-Modifying Therapy-Naive Multiple Sclerosis Patients
|
Khedr, Eman M |
|
|
92 |
C |
p. |
artikel |
201 |
100. Serum Derived microRNA as a Diagnostic Biomarker for Multiple Sclerosis Subtypes in Saudi Population: A Pilot Study
|
Zailaie, Samar Abdullah |
|
|
92 |
C |
p. |
artikel |
202 |
27. Serum Neurofilament Light Chain as a Diagnostic Marker in Drug-Naive Multiple Sclerosis Patients: A Cross-Sectional Hospital Based Study
|
Khedr, Eman Mohammed |
|
|
92 |
C |
p. |
artikel |
203 |
83. Serum Neurofilament Light Chain Levels and Glial Fibrillary Acidic Protein are Prognostic Biomarkers of Disability Worsening in Multiple Sclerosis Patients
|
Hassoun, Hayder K. |
|
|
92 |
C |
p. |
artikel |
204 |
Sex differences in use of potentially teratogenic disease modifying treatments for multiple sclerosis and degree of hormonal contraception overlap in women between 2007–2021: An Australian population-based study
|
Fragkoudi, A. |
|
|
92 |
C |
p. |
artikel |
205 |
77. Sleep Disturbances and Associated Factors in Multiple Sclerosis
|
Hamed, Nouha Ben |
|
|
92 |
C |
p. |
artikel |
206 |
78. Sleep Quality Among People with Multiple Sclerosis: Application of the International Classification of Functioning, Disability, and Health Model
|
Al-Sharman, Alham |
|
|
92 |
C |
p. |
artikel |
207 |
12. Sleep Quality Is Not a Predictor of Information Process Speed in Multiple Sclerosis: A Systematic Review and Meta-analysis
|
Naseri, Amirreza |
|
|
92 |
C |
p. |
artikel |
208 |
Smouldering-associated worsening or SAW: the next therapeutic challenge in managing multiple sclerosis
|
Giovannoni, Gavin |
|
|
92 |
C |
p. |
artikel |
209 |
80. Status of Cerebrospinal Fluid Oligoclonal Bands among Patients with Multiple Sclerosis at King Abdulaziz Medical City
|
Abulaban, Ahmad Abdulaziz |
|
|
92 |
C |
p. |
artikel |
210 |
Step to the beat: Auditory-motor coupling during walking to higher and lower tempi with music and metronomes in progressive multiple sclerosis: An observational study
|
Vanbilsen, Nele |
|
|
92 |
C |
p. |
artikel |
211 |
71. Stroke Incidence in Multiple Sclerosis: A Systematic Review and Meta-Analysis
|
Ketata, Imen |
|
|
92 |
C |
p. |
artikel |
212 |
79. Sustained Treatment Persistence and High Adherence to Cladribine Tablets in Multiple Sclerosis: Results from Patient Support Program in Gulf Countries
|
Alroughani, Raed |
|
|
92 |
C |
p. |
artikel |
213 |
30. Thalamic Volume Differentiates Multiple Sclerosis from Neuromyelitis Optica Spectrum Disorder
|
Aljarallah, Salman |
|
|
92 |
C |
p. |
artikel |
214 |
90. The Clinical and Neurochemical Effect of Transcranial Magnetic Stimulation on the Unusual Symptoms of Multiple Sclerosis
|
Tohamy, Amal |
|
|
92 |
C |
p. |
artikel |
215 |
10. The Comparative Ability of Five Mobility and Balance Outcome Measures in Predicting the Risk of Falls in People with Multiple Sclerosis
|
Khalil, Hanan |
|
|
92 |
C |
p. |
artikel |
216 |
51. The Comparative Effectiveness of Natalizumab and Anti-CD20 Monoclonal Antibodies in Relapsing-Remitting Multiple Sclerosis: A Real-World based Study
|
Zeineddine, Maya |
|
|
92 |
C |
p. |
artikel |
217 |
The correlation between rituximab dose reduction and acute relapses of neuromyelitis optica spectrum disorder, lessons from COVID-19 epidemic
|
Ashtari, Fereshteh |
|
|
92 |
C |
p. |
artikel |
218 |
113. The Correlation Between Serum Neurofilaments Levels and Brain Iron Load and 2D Brain Volume Parameters: A Pilot Study
|
Hamdy, Eman |
|
|
92 |
C |
p. |
artikel |
219 |
20. The Design of National Neuromyelitis Optica Spectrum Disorders Registry System of Iran
|
Eskandarieh, Sharareh |
|
|
92 |
C |
p. |
artikel |
220 |
158. The Impact of Natalizumab on Neuropsychological Function in Multiple Sclerosis Patients
|
Zouari, Rania |
|
|
92 |
C |
p. |
artikel |
221 |
104. The Influence of Parental Autoimmune Diseases on the Development of Multiple Sclerosis: Findings from a Case-Control Study
|
Khodadadi, Sanaz |
|
|
92 |
C |
p. |
artikel |
222 |
The multiple sclerosis gut microbiome and disease activity: A systematic review
|
Jette, Sophia |
|
|
92 |
C |
p. |
artikel |
223 |
39. The Neuroimmunological Manifestations of Covid-19 the Most Extensive Review of Published Case Reports
|
Al-Draye, Hamad |
|
|
92 |
C |
p. |
artikel |
224 |
120. The Pathological Findings of the First Cervical Spine MRI of The Neuromyelitis Optica Spectrum Disorders Patients
|
Mehdipour, Roshanak |
|
|
92 |
C |
p. |
artikel |
225 |
The perspectives of neurologists on positron emission tomography utility in multiple sclerosis: A qualitative study
|
Ezzat, Daniel |
|
|
92 |
C |
p. |
artikel |
226 |
4. The Prevalence of Comorbidities Associated with Multiple Sclerosis in Saudi Arabia
|
Alnajashi, Hind |
|
|
92 |
C |
p. |
artikel |
227 |
124. The Prevalence of Iron Overload in Patients with Multiple Sclerosis in National Guard Health Affair Hospital, Riyadh Center from 2015-2021
|
Alanazi, Asma |
|
|
92 |
C |
p. |
artikel |
228 |
181. The Real-world Efficacy and Safety of Off-label Rituximab in a Large Cohort of Middle Eastern Multiple Sclerosis Patients
|
Ismail, Ghida |
|
|
92 |
C |
p. |
artikel |
229 |
The real-world impact of biologics for NMOSD: A retrospective single-center study compared with natural course and conventional treatments in Japanese
|
Yamazaki, Naoya |
|
|
92 |
C |
p. |
artikel |
230 |
84. The Relationship between Fatigue and MRI Volumetric Markers among Patients with Early Relapsing-remitting Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder
|
Ashtari, Fereshteh |
|
|
92 |
C |
p. |
artikel |
231 |
The role of disease modifying therapies in late-onset multiple sclerosis: A Portuguese multicentric characterization study
|
Faustino, Patrícia |
|
|
92 |
C |
p. |
artikel |
232 |
2. Triaging Multiple Sclerosis at the Emergency Department: A Proposed Algorithmic Approach
|
Al-Draye, Hamad |
|
|
92 |
C |
p. |
artikel |
233 |
121. Tumefactive Myelin Oligodendrocyte-Associated Disease Presenting as Acute Flaccid Myelitis: A Case Report
|
Haroun, Lynda |
|
|
92 |
C |
p. |
artikel |
234 |
145. Two-year Results of Patient-Reported Outcomes in Patients with Multiple Sclerosis Treated with Ocrelizumab in a Large Real-World Setting: MuSicalE Interim Analysis
|
Trojano, Maria |
|
|
92 |
C |
p. |
artikel |
235 |
36. Uncommon Initial Presentation of Neuromyelitis Optica Spectrum Disorder: Short-lasting Unilateral Neuralgiform Headache with Autonomic Symptoms (SUNA)- A Case report
|
Adjmi, Roumaissa Rekia |
|
|
92 |
C |
p. |
artikel |
236 |
37. Underemployment, Work Hour Reduction, and Income Loss: A Global, Multi-centered, Cohort Study of Neuromyelitis Optica
|
Hjerthen, Isabella Gomez |
|
|
92 |
C |
p. |
artikel |
237 |
87. Understanding the Potential Therapeutic and Rehabilitative Role of Transcranial Magnetic Stimulation in Multiple Sclerosis
|
Bashir, Shahid |
|
|
92 |
C |
p. |
artikel |
238 |
33. Unmasking Stroke Presentation for Elderly Onset Demyelination
|
Galeel, Aya Abdel |
|
|
92 |
C |
p. |
artikel |
239 |
165. Unmet Needs and Treatment of Relapsing-Remitting Multiple Sclerosis in Saudi Arabia: Focus on the Role of Ofatumumab
|
Craner, Matthew |
|
|
92 |
C |
p. |
artikel |
240 |
Untackling the economics of multiple sclerosis: A systematic review of economic evaluations of disease-modifying therapies indicated for multiple sclerosis
|
Petrou, Dr Panagiotis |
|
|
92 |
C |
p. |
artikel |
241 |
111. Usefulness of Phase Sensitive Inversion Recovery MRI Sequence in the Detection of Cortical Lesions in Multiple Sclerosis
|
Shakir, Rezq Ahmed |
|
|
92 |
C |
p. |
artikel |
242 |
Utility of icobrain for brain volumetry in multiple sclerosis clinical practice
|
Nguyen, Ai-Lan |
|
|
92 |
C |
p. |
artikel |
243 |
96. Value of Central Vein Sign in Differentiating Between Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
|
Galeel, Aya Abdel |
|
|
92 |
C |
p. |
artikel |
244 |
23. Vanishing Clues: A Systematic Review of Oligoclonal Band Disappearance in Multiple Sclerosis Patients after Treatment
|
Al-Draye, Hamad |
|
|
92 |
C |
p. |
artikel |
245 |
Vitamin D and cardiovascular outcomes in multiple sclerosis
|
France-Ratcliffe, Madeleine |
|
|
92 |
C |
p. |
artikel |
246 |
102. When Multiple Sclerosis and Neuro Behcet Disease Meet: What Management to Adopt?
|
Kediha, Mohamed Islam |
|
|
92 |
C |
p. |
artikel |